7TJQ image
Deposition Date 2022-01-16
Release Date 2022-09-14
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7TJQ
Title:
SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.13 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:SAN27-14 Fab heavy chain
Chain IDs:A, D, H
Chain Length:124
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:SAN27-14 Fab light chain
Chain IDs:B, E, L
Chain Length:115
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Fusion glycoprotein F0
Mutations:Q100R, S101R, L110C, T127C, A140C, N153C, A147C, A185P, L219K, V231I, G294E, N322C, T365C, E453Q, V463C
Chain IDs:C, F, G
Chain Length:551
Number of Molecules:3
Biological Source:Human metapneumovirus
Polymer Type:polypeptide(L)
Molecule:MPE8 Fab heavy chain
Chain IDs:I, J, N
Chain Length:230
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:MPE8 Fab light chain
Chain IDs:K, M, O
Chain Length:214
Number of Molecules:3
Biological Source:Homo sapiens
Primary Citation
Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus.
Cell Rep 40 111399 111399 (2022)
PMID: 36130517 DOI: 10.1016/j.celrep.2022.111399

Abstact

Human metapneumovirus (hMPV) is a major cause of acute respiratory infections in infants and older adults, for which no vaccines or therapeutics are available. The viral fusion (F) glycoprotein is required for entry and is the primary target of neutralizing antibodies; however, little is known about the humoral immune response generated from natural infection. Here, using prefusion-stabilized F proteins to interrogate memory B cells from two older adults, we obtain over 700 paired non-IgM antibody sequences representing 563 clonotypes, indicative of a highly polyclonal response. Characterization of 136 monoclonal antibodies reveals broad recognition of the protein surface, with potently neutralizing antibodies targeting each antigenic site. Cryo-EM studies further reveal two non-canonical sites and the molecular basis for recognition of the apex of hMPV F by two prefusion-specific neutralizing antibodies. Collectively, these results provide insight into the humoral response to hMPV infection in older adults and will help guide vaccine development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures